{"entity":{"type":"insider","cik":"0001785987","url":"/insider/0001785987","json_url":"/insider/0001785987.json","name":"Larson Yi","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":2,"first":"2019-09-11","last":"2021-02-02","span_basis":"filed_date"},"name_variants":[{"name":"Larson Yi","source":"filing","n_filings":2,"first_seen":"2019-09-11","last_seen":"2021-02-02"}],"transactions":[{"id":4658017,"accession":"0001209191-21-007037","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-21-007037","line_url":"/filing/0001209191-21-007037","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001785987","owner_name":"Larson Yi","owner_display_name":"Larson Yi","owner_url":"/insider/0001785987","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14298.0,"shares_display":"14,298","price_per_share":130.14496223248005,"price_display":"130.14","price_state":"stated","total_value":1860812.67,"total_display":"1,860,812.67","total_whole":"1,860,813","shares_owned_after":3761.0,"shares_owned_after_display":"3,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-02","scope":"insider","n_lines":5},{"id":4657979,"accession":"0001209191-21-007037","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-007037","line_url":"/filing/0001209191-21-007037","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001785987","owner_name":"Larson Yi","owner_display_name":"Larson Yi","owner_url":"/insider/0001785987","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15702.0,"shares_display":"15,702","price_per_share":123.6215144567571,"price_display":"123.62","price_state":"stated","total_value":1941105.02,"total_display":"1,941,105.02","total_whole":"1,941,105","shares_owned_after":5047.0,"shares_owned_after_display":"5,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-02","scope":"insider","n_lines":4},{"id":8759640,"accession":"0001209191-19-049153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049153","line_url":"/filing/0001209191-19-049153#line-1","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001785987","owner_name":"Larson Yi","owner_display_name":"Larson Yi","owner_url":"/insider/0001785987","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2222.0,"shares_display":"2,222","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":99990.0,"total_display":"99,990.00","total_whole":"99,990","shares_owned_after":2222.0,"shares_owned_after_display":"2,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Officer (EVP & Chief Financial Officer)","n_filings":2,"first_seen":"2019-09-11","last_seen":"2021-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001785987","retrieved_at":"2026-08-27T00:02:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}